首页> 外文OA文献 >Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors

【2h】

Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors

机译：近几十年患有激素受体阳性，海洋阴性乳腺癌患者的整体存活率提高：预后因素的单中心回顾性分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yoko Yamada; Hirofumi Mukai; Yuta Tokudome; Motoko Kaneko; Kosuke Kashiwabara; Noriaki Wada;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors [J] . YokoYamada, HirofumiMukai, YutaTokudome, Japanese journal of clinical oncology. . 2018,第3期

机译：近几十年患者患有激素受体阳性，HER2阴性乳腺癌患者的整体存活：单中心回顾性对预后因素分析
2. A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: An analysis of the ATHENA trial [J] . Llombart-CussacA., PivotX., BiganzoliL., The Breast : . 2014,第5期

机译：一线化疗治疗HER2阴性晚期乳腺癌的一线化疗患者总体生存的预后因素指数：ATHENA试验分析
3. Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors. [J] . Gilabert M, Bertucci F, Esterni B, Anticancer Research: International Journal of Cancer Research and Treatment . 2011,第3期

机译：蒽环类和紫杉烷类药物暴露于HER2阴性转移性乳腺癌患者中的卡培他滨：应答，生存和预后因素。
4. Application of artificial neural network and multiple linear regression models for predicting survival time of patients with non-small cell cancer using multiple prognostic factors including FDG-PET measurements [C] . Pu Yonglin, Baad Michael J., Jiang Yulei, International Joint Conference on Neural Networks . 2014

机译：人工神经网络和多元线性回归模型在包括FDG-PET测量在内的多种预后因素预测非小细胞癌患者生存时间中的应用
5. Prognostic significance of some clinical, histopathological and biological parameters for survival of node-negative breast cancer patients treated in University Medical centre Maribor in the period 2000-2009 [D] . Fokter Dovnik, Nina. 2017

机译：2000 - 2009年在大学医疗中心管理中的节点阴性乳腺癌患者中临床，组织病理学和生物学参数的预后意义
6. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer [O] . Ling Xu, Jiang-Hong Li, Jing-Ming Ye, 2017

机译：基于美国癌症联合委员会第8版Luminal B人表皮生长因子受体2阴性乳腺癌的癌症分期手册对解剖和预后阶段组进行回顾性生存分析。
7. A Retrospective Survival Analysis of Anatomic and Prognostic Stage Group Based on the American Joint Committee on Cancer 8th Edition Cancer Staging Manual in Luminal B Human Epidermal Growth Factor Receptor 2-negative Breast Cancer [O] . Ling Xu, Jiang-Hong Li, Jing-Ming Ye, 2017

机译：基于美国肿瘤联合委员会第8版癌症分期手册Luminal B人类表皮生长因子受体2阴性乳腺癌的解剖和预后阶段组的回顾性生存分析

Improved overall survival over recent decades in patients with hormone-receptor-positive, HER2-negative breast cancer: a single-center retrospective analysis of prognostic factors

著录项

引文网络

相似文献

相关主题

期刊订阅